Pembrolizumab-Mediated Complete Remission of a PLA2R-Positive Paraneoplastic Membranous Nephropathy: A Case Report

Management of paraneoplastic membranous nephropathy (MN) is directed toward the underlying malignancy, and prescriptions of immune checkpoint inhibitors (ICIs) are skyrocketing in the field of oncology. However, this drug category is usually discouraged for patients with autoimmune disorders (AIDs)...

Descripción completa

Detalles Bibliográficos

Autores principales:	Rayane Benyahia, Magali Colombat, Serigne Gueye, Julien Mazières, Julie Belliere
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2025-04-01
Colección:	Kidney Medicine
Materias:	Case report immune checkpoint inhibitor immune-related adverse event lung adenocarcinoma membranous nephropathy pembrolizumab
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2590059525000032
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!